+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Pyrogen Testing Market by Product Type (Assays, Kits, & Reagents, Instruments, Services), Test Type (Limulus Amoebocyte Lysate, Monocyte Activation Test, Rabbit Tests), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 190 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968889
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Pyrogen Testing Market grew from USD 1.24 billion in 2023 to USD 1.38 billion in 2024. It is expected to continue growing at a CAGR of 11.64%, reaching USD 2.68 billion by 2030.

Pyrogens are substances that, even in small amounts, can induce fever when introduced into the human body. These substances primarily include bacterial endotoxins, which are constituents of Gram-negative bacteria cell walls, and other microbial and non-microbial contaminants that elicit a pyrogenic response. Increased awareness and vigilance regarding drug safety and efficacy have heightened the focus on contaminant testing, including pyrogens. Moreover, stringent regulations and standards set by health authorities worldwide necessitate comprehensive pyrogen testing, fuelling demand for testing services and products. However, the high cost of advanced pyrogen testing methods can be prohibitive, especially for small and medium-sized enterprises (SMEs). Furthermore, the growing shift towards animal-free testing methods presents significant opportunities for innovation in synthetic and recombinant pyrogen testing methods.

Regional Insights

The Americas, particularly the United States and Canada, represent a substantial market for pyrogen testing. The Americas market is attributed to the advanced healthcare infrastructure, strict regulatory policies, and the presence of key pharmaceutical and biotechnology companies. The United States stands out with its robust research ecosystem, leading to innovative testing solutions. The market is buoyed by FDA regulations that mandate rigorous pyrogen testing for all injectable and implantable medical devices. The EU countries are leading in regulatory standards and market size with the adoption of the European Pharmacopoeia standards, which underscores the commitment to ensuring product safety through rigorous pyrogen testing. The demand for pyrogen testing is driven by a large pharmaceutical industry base and heightened awareness regarding product safety. The Middle East and Africa present a nascent market with growing potential. The interest in pyrogen testing is increasing with the expansion of healthcare infrastructure and pharmaceutical manufacturing capabilities. The Asia Pacific region is witnessing rapid growth in the pyrogen testing market driven by expanding pharmaceutical industries in countries including China, Japan, and India. The region benefits from increasing investments in healthcare and research, coupled with a heightened focus on quality control and safety standards.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Pyrogen Testing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Rising incidence of infectious diseases and chronic diseases
  • Increasing production of pharmaceuticals, biologics, and medical devices products
  • Stringent regulations and standards set by health authorities worldwide

Market Restraints

  • High cost associated with the advanced pyrogen testing methods

Market Opportunities

  • Increasing investments in R&D activities by pharmaceutical and biotechnology companies
  • Technological advancements in biotechnology and pyrogen testing technologies

Market Challenges

  • Operational and ethical concerns associated with the pyrogen testing

Market Segmentation Analysis

  • Product Type: Increasing demand of assays, kits, & reagents to automate, facilitate, or enhance the testing processes
  • End-User: Increasing demand of pyrogen testing across biotechnology companies

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Pyrogen Testing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Pyrogen Testing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Charles River Laboratories Launches Endosafe Trillium rCR Cartridge for Efficient, Animal-Free Testing

Charles River Laboratories International, Inc. significantly enhances its endotoxin testing capabilities with the introduction of the Endosafe Trillium recombinant cascade reagent (rCR) cartridge. This innovative offering extends the functionality of Charles River's established Endosafe cartridge technology by incorporating a revolutionary animal-free testing solution, thereby advancing efficiency, reducing human error, and accelerating production timelines.

Lonza Introduces Advanced Rapid MAT Systems

Lonza has unveiled two innovative monocyte activation test (MAT) systems, the PyroCell MAT Rapid System and the PyroCell MAT Human Serum (HS) Rapid System, significantly enhancing the efficiency of rabbit-free pyrogen testing. These platforms incorporate the novel PeliKine Human IL-6 Rapid ELISA Kit, which dramatically reduces the hands-on time and overall time-to-results from two days to merely two hours, facilitating a more streamlined and quick analysis.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Pyrogen Testing Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Pyrogen Testing Market, highlighting leading vendors and their innovative profiles. These include Accugen Laboratories, Inc., Associates of Cape Cod, Inc., bioMérieux SA, Charles River Laboratories International, Inc., Corning Incorporated, Ellab A/S by Novo Nordisk A/S, Eurofins Scientific SE, FUJIFILM Corporation, GenScript Biotech Corporation, Indoor Biotechnologies, Inc., Lonza Group, MAT BioTech BV, Merck KGaA, Microcoat Biotechnologie GmbH, Minerva Analytix GmbH by Dilarus GmbH, Nelson Laboratories, LLC by Sotera Health, North American Science Associates, LLC, Pacific BioLabs, Solvias AG, Steris PLC, Thermo Fisher Scientific Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Pyrogen Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type

  • Assays, Kits, & Reagents
  • Instruments
  • Services
  • Test Type

Limulus Amoebocyte Lysate

  • Chromogenic Tests
  • Gel Clot Tests
  • Turbidimetric Tests
  • Monocyte Activation Test
  • Rabbit Tests
  • Recombinant Cascade Reagent
  • Recombinant Factor C

End-User

  • Biotechnology Companies
  • Medical Device Companies
  • Pharmaceutical Companies

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of infectious diseases and chronic diseases
5.1.1.2. Increasing production of pharmaceuticals, biologics, and medical devices products
5.1.1.3. Stringent regulations and standards set by health authorities worldwide
5.1.2. Restraints
5.1.2.1. High cost associated with the advanced pyrogen testing methods
5.1.3. Opportunities
5.1.3.1. Increasing investments in R&D activities by pharmaceutical and biotechnology companies
5.1.3.2. Technological advancements in biotechnology and pyrogen testing technologies
5.1.4. Challenges
5.1.4.1. Operational and ethical concerns associated with the pyrogen testing
5.2. Market Segmentation Analysis
5.2.1. Product Type: Increasing demand of assays, kits, & reagents to automate, facilitate, or enhance the testing processes
5.2.2. End-User: Increasing demand of pyrogen testing across biotechnology companies
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Pyrogen Testing Market, by Product Type
6.1. Introduction
6.2. Assays, Kits, & Reagents
6.3. Instruments
6.4. Services
7. Pyrogen Testing Market, by Test Type
7.1. Introduction
7.2. Limulus Amoebocyte Lysate
7.3. Monocyte Activation Test
7.4. Rabbit Tests
7.5. Recombinant Cascade Reagent
7.6. Recombinant Factor C
8. Pyrogen Testing Market, by End-User
8.1. Introduction
8.2. Biotechnology Companies
8.3. Medical Device Companies
8.4. Pharmaceutical Companies
9. Americas Pyrogen Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Pyrogen Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Pyrogen Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Charles River Laboratories Launches Endosafe Trillium rCR Cartridge for Efficient, Animal-Free Testing
12.3.2. Lonza Introduces Advanced Rapid MAT Systems
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. PYROGEN TESTING MARKET RESEARCH PROCESS
FIGURE 2. PYROGEN TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PYROGEN TESTING MARKET DYNAMICS
FIGURE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PYROGEN TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. PYROGEN TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PYROGEN TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL PYROGEN TESTING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL PYROGEN TESTING MARKET SIZE, BY RABBIT TESTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL PYROGEN TESTING MARKET SIZE, BY RABBIT TESTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT CASCADE REAGENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT CASCADE REAGENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL PYROGEN TESTING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL PYROGEN TESTING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 69. CANADA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 70. CANADA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 71. CANADA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 72. CANADA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 73. CANADA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 74. CANADA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 75. CANADA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 76. CANADA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 77. MEXICO PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 78. MEXICO PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 79. MEXICO PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 80. MEXICO PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 81. MEXICO PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 82. MEXICO PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 83. MEXICO PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 84. MEXICO PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 94. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 104. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 105. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 106. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 107. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 108. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 109. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 110. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 111. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 112. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 113. CHINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 114. CHINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 115. CHINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 116. CHINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 117. CHINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 118. CHINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 119. CHINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 120. CHINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 121. INDIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 122. INDIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 123. INDIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 124. INDIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 125. INDIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 126. INDIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 127. INDIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 128. INDIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 129. INDONESIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 130. INDONESIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 131. INDONESIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 132. INDONESIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 133. INDONESIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 134. INDONESIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 135. INDONESIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 136. INDONESIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 137. JAPAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 138. JAPAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 139. JAPAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 140. JAPAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 141. JAPAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 142. JAPAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 143. JAPAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 144. JAPAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 145. MALAYSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 146. MALAYSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 147. MALAYSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 148. MALAYSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 149. MALAYSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 150. MALAYSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 151. MALAYSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 152. MALAYSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 153. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 154. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 155. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 156. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 157. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 158. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 159. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 160. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 161. SINGAPORE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 162. SINGAPORE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 163. SINGAPORE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 164. SINGAPORE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 165. SINGAPORE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 166. SINGAPORE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 167. SINGAPORE PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 168. SINGAPORE PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 169. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 170. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 171. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 172. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 173. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 174. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 175. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 176. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 177. TAIWAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 178. TAIWAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 179. TAIWAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 180. TAIWAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 181. TAIWAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 182. TAIWAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 183. TAIWAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 184. TAIWAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 185. THAILAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 186. THAILAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 187. THAILAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 188. THAILAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 189. THAILAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 190. THAILAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 191. THAILAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 192. THAILAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 193. VIETNAM PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 194. VIETNAM PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 195. VIETNAM PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 196. VIETNAM PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 197. VIETNAM PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 198. VIETNAM PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 199. VIETNAM PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 200. VIETNAM PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 211. DENMARK PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 212. DENMARK PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 213. DENMARK PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 214. DENMARK PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 215. DENMARK PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 216. DENMARK PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 217. DENMARK PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 218. DENMARK PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 219. EGYPT PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 220. EGYPT PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 221. EGYPT PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 222. EGYPT PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 223. EGYPT PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 224. EGYPT PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 225. EGYPT PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 226. EGYPT PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 227. FINLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 228. FINLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 229. FINLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 230. FINLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 231. FINLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 232. FINLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 233. FINLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 234. FINLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 235. FRANCE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 236. FRANCE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 237. FRANCE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 238. FRANCE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 239. FRANCE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 240. FRANCE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 241. FRANCE PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 242. FRANCE PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 243. GERMANY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 244. GERMANY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 245. GERMANY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 246. GERMANY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 247. GERMANY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 248. GERMANY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 249. GERMANY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 250. GERMANY PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 251. ISRAEL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 252. ISRAEL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 253. ISRAEL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 254. ISRAEL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 255. ISRAEL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 256. ISRAEL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 257. ISRAEL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 258. ISRAEL PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 259. ITALY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 260. ITALY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 261. ITALY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 262. ITALY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 263. ITALY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 264. ITALY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 265. ITALY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 266. ITALY PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 267. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 268. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 269. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 270. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 271. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 272. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 273. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 274. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 275. NIGERIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 276. NIGERIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 277. NIGERIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 278. NIGERIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 279. NIGERIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 280. NIGERIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 281. NIGERIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 282. NIGERIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 283. NORWAY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 284. NORWAY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 285. NORWAY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 286. NORWAY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 287. NORWAY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 288. NORWAY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 289. NORWAY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 290. NORWAY PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 291. POLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 292. POLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 293. POLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 294. POLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 295. POLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 296. POLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 297. POLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 298. POLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 299. QATAR PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 300. QATAR PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 301. QATAR PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 302. QATAR PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 303. QATAR PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 304. QATAR PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 305. QATAR PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 306. QATAR PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 307. RUSSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 308. RUSSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 309. RUSSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 310. RUSSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 311. RUSSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 312. RUSSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 313. RUSSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 314. RUSSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 316. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 318. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 320. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 322. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 324. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 326. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 328. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 330. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 331. SPAIN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 332. SPAIN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 333. SPAIN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 334. SPAIN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 335. SPAIN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 336. SPAIN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 337. SPAIN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 338. SPAIN PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 339. SWEDEN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 340. SWEDEN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 341. SWEDEN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 342. SWEDEN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 343. SWEDEN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 344. SWEDEN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 345. SWEDEN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 346. SWEDEN PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 347. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 348. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
TABLE 349. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 350. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 351. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2023 (USD MILLION)
TABLE 352. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2024-2030 (USD MILLION)
TABLE 353. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 354. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 355. TURKEY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
TABLE 356. TURKEY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE

Companies Mentioned

  • Accugen Laboratories, Inc.
  • Associates of Cape Cod, Inc.
  • bioMérieux SA
  • Charles River Laboratories International, Inc.
  • Corning Incorporated
  • Ellab A/S by Novo Nordisk A/S
  • Eurofins Scientific SE
  • FUJIFILM Corporation
  • GenScript Biotech Corporation
  • Indoor Biotechnologies, Inc.
  • Lonza Group
  • MAT BioTech BV
  • Merck KGaA
  • Microcoat Biotechnologie GmbH
  • Minerva Analytix GmbH by Dilarus GmbH
  • Nelson Laboratories, LLC by Sotera Health
  • North American Science Associates, LLC
  • Pacific BioLabs
  • Solvias AG
  • Steris PLC
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec

Methodology

Loading
LOADING...

Table Information